- CA$21.42m
- CA$21.18m
Annual balance sheet for VVT Med, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | fx Final | fx Final |
| Cash | |||||
| Cash and Short Term Investments | 0.057 | 0.015 | 0.013 | 0.018 | 0.017 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.002 | 0 | — | — | — |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.064 | 0.02 | 0.017 | 0.021 | 0.019 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.002 | 0.001 | 0.001 | 0 | — |
| Other Long Term Assets | |||||
| Total Assets | 0.065 | 0.021 | 0.018 | 0.021 | 0.019 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.373 | 0.523 | 0.588 | 0.744 | 0.794 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.373 | 0.523 | 0.588 | 0.744 | 0.794 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.308 | -0.503 | -0.571 | -0.723 | -0.775 |
| Total Liabilities & Shareholders' Equity | 0.065 | 0.021 | 0.018 | 0.021 | 0.019 |
| Total Common Shares Outstanding |